Financial Results for the Quarter Ended March 31, 2025 Net income allocable to common stockholders was $15.0 million, or $0.85 per diluted share as compared to $17.0 million, or $1.04 per diluted share in the prior quarter. The drivers of the periodic change are discussed in detail in the following sections. Net Interest Income Net
NeOnc Technologies Holdings, Inc. — 176 Patents Issued and Outstanding Reinforces NeOnc’s Competitive Position — CALABASAS, Calif., April 15, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a biopharmaceutical company focused on the development of novel oncology and neurology therapeutics, today announced that its global patent portfolio totals 176, reinforcing its competitive position.
Tilray Brands, Inc. Tilray Confirms No Current Impact of Tariffs Generated Net Revenue of $186 Million in the Third Quarter, $193 Million in Constant Currency; Strategic Initiatives and SKU Rationalization Impacted Revenue by $13 Million Tilray Beverage Expands U.S. Distribution of Hemp-Derived THC Drinks Across 10 States, Increases Project 420 Cost Savings Plan to $33
FRANKLIN, Tenn., April 02, 2025–(BUSINESS WIRE)–Kaiser Aluminum Corporation (NASDAQ: KALU) (“Kaiser” or the “Company”) today announced that it plans to release its first quarter 2025 financial and operating results on Wednesday, April 23, 2025, after the market closes. The Company will host its quarterly conference call on Thursday, April 24, 2025, at 10:00 a.m. Eastern
The segment’s operating and Adjusted EBITDA margin increases were primarily due to lower merchandise and production costs as a percentage of revenues. These were partially offset by higher healthcare claims expense and selling and administrative costs as a percentage of revenues in the second quarter of fiscal 2025. Specialty Garments Revenues for the quarter were $44.4
Project will add strong recurring revenue stream to current portfolio VANCOUVER, BC / ACCESS Newswire / April 1, 2025 / Revolve Renewable Power Corp. (TSXV:REVV)(OTCQB:REVVF) (“Revolve” or the “Company“), a North American owner, operator and developer of renewable energy projects, is pleased to announce that it has signed a binding offer (the “Binding Offer“) for
TORONTO, March 31, 2025–(BUSINESS WIRE)–Kontrol Technologies Corp. (CBOE.CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company”) announces its results for the three months and fiscal year ended December 31, 2024. A complete set of the Financial Statements and Management’s Discussion & Analysis have been filed on SEDAR (www.sedarplus.ca). Fourth Quarter and Fiscal Year 2024 Highlights
During fiscal 2024, “Net Other Income (Expense)” included $29.1 million in other investment income mainly driven by a $17.0 million unrealized gain on the Sky Harbour warrants held by Boston Omaha, other investment income of $7.8 million primarily related to the sale of real estate properties and changes in the fair value of remaining assets
Prairie Operating Co. Pro-Forma Reserve Data Pro-Forma Reserve Data Reconciliation of Non-GAAP Measure Reconciliation of Non-GAAP Measure Expands footprint in DJ Basin to ~55,000 net acres and inventory life to ~10 years Increases average daily production by ~25,700 net BOEPD Immediately accretive and maintains strong balance sheet Houston, TX, March 26, 2025 (GLOBE NEWSWIRE) —
– Phase 3 EMPEROR study of zorevunersen, a first-in-class potential disease-modifying medicine for Dravet syndrome, on track to initiate in 2Q 2025 – – As of December 31, 2024, the Company had $246.7 million in cash, cash equivalents, and marketable securities; together with the $165 million upfront and eligible proceeds from Biogen collaboration anticipated to